Retraction Watch

Sage slaps more than 100 papers from one journal with expressions of concern

The Sage journal American Surgeon has issued a mass expression of concern for 116 articles.

The expression of concern states the journal “was made aware” of “concerning author activity” on the articles.

Sage is no stranger to mass editorial actions. In 2023, the publisher pulled large tranches of papers at least three times, and last year it retracted over 450 papers from a journal the company had acquired from IOS Press. The publisher was one of the first to begin retracting papers in bulk, primarily to combat manipulated peer review.

‘Still angry’: Chemist finds his name on a study he didn’t write

Last October, Martin McPhillie, a lecturer in organic chemistry at the UK’s University of Leeds, received an email alert from his institution about a new article bearing his name.

The article, “Docking Study of Licensed Non-Viral Drugs to Obtain Ebola Virus Inhibitors,” appeared in the Journal of Biochemical Technology, a title of Istanbul, Turkey-based Deniz Publication. The journal is not indexed in Clarivate’s Web of Science database.

The study was within McPhillie’s area of expertise, and aligned with work he and the other listed coauthors had previously published. But he knew the new study wasn’t his.

Weekend reads: ‘Lack of informed consent’ in DNA data; protecting the ‘prey’ of predatory journals; another ivermectin-COVID-19 retraction

Dear RW readers, can you spare $25?

The week at Retraction Watch featured:

Meet Retraction Watch’s two new journalists
Elsevier denies AI use in response to evolution journal board resignations
Biotech company agrees to pay $4 million to settle data falsification allegations
Science paper by Toronto lab retracted
The 14 universities with publication metrics researchers say are too good to be true

Our list of retracted or withdrawn COVID-19 papers is up past 450. There are more than 50,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers? What about The Retraction Watch Mass Resignations List — or our list of nearly 100 papers with evidence they were written by ChatGPT?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

The 14 universities with publication metrics researchers say are too good to be true

Saveetha Institute of Medical and Technical Sciences

More than a dozen universities have used “questionable authorship practices” to inflate their publication metrics, authors of a new study say. One university even saw an increase in published articles of nearly 1,500% in the last four years.

The study, published January 5 in Quantitative Science Studies, “intends to serve as a starting point for broader discussions on balancing the pressures of global competition with maintaining ethical standards in research productivity and authorship practice,” study authors Lokman Meho and Elie Akl, researchers at the American University of Beirut in Lebanon, told Retraction Watch.

Science paper by Toronto lab retracted

Anomalies in Figure 1 of a 2014 *Science* paper, a portion of which is shown here, is one of several in question in a retraction published in the January 10 *Science*. *Source*

A 2014 paper in Science by a lab in Toronto has been retracted after a December expression of concern raised “potential data integrity issues.”

The paper, “Mitosis Inhibits DNA Double-Strand Break Repair to Guard Against Telomere Fusions,” is from the lab of Daniel Durocher, a professor of molecular genetics at the University of Toronto.

The retraction notice, published today and signed by all of the original authors, reads, in part:

Biotech company agrees to pay $4 million to settle data falsification allegations

A biotech company whose CEO faced allegations of manipulating data in papers used in NIH grant applications will pay a settlement of $4 million to resolve those allegations, the Department of Justice announced January 6.

The settlement is the latest installment in a series of allegations surrounding research by Leen Kawas, the former CEO of the company, Bothell, Wash.-based Athira Pharma. In October 2021, four months after placing cofounder and then-CEO Kawas on leave, an internal investigation found she falsified images in her doctoral dissertation and at least four research papers.

But concerns had been raised about the images as early as 2016, and Athira failed to report them, the DOJ statement noted. Those papers “were referenced in several grant applications submitted to NIH, including in a grant that NIH funded in 2019,” the statement continued.

Elsevier denies AI use in response to evolution journal board resignations

The publisher of the Journal of Human Evolution says it does not use artificial intelligence in its production process, contrary to a statement issued last month by the journal’s editorial board when all but one member of the group resigned.

The statement, shared on X on December 26, noted the journal’s “joint Editors-in-Chief, all Emeritus Editors retired or active in the field, and all but one Associate Editor” were resigning because Elsevier, the journal’s publisher, “has steadily eroded the infrastructure essential to the success of the journal while simultaneously undermining the core principles and practices that have successfully guided the journal for the past 38 years.” Among the examples cited:

Meet Retraction Watch’s two new journalists

Kate Travis (left) and Avery Orrall (right)

Please join us in welcoming two new Retraction Watch staff members: Managing editor Kate Travis, and reporter Avery Orrall.

Kate comes to us with a long and impressive resume. She has served as digital director at Science News, an editor for Science’s careers website, Science Careers, and news editor of the Journal of the National Cancer Institute. She contributed a chapter to A Tactical Guide to Science Journalism, is the coordinator of the National Association of Science Writers’ Science in Society Journalism Awards, and serves as the part-time managing editor of Connector, an online library of resources on science writing produced by the Council for the Advancement of Science Writing. Reach her at [email protected].

Avery’s name will be familiar to readers, as she was one of our two summer interns last year and has since been our newsletter editor. She is a recent graduate of New York University’s Science, Health and Environmental Reporting Program, and has also interned at JAMA Medical News. Reach her at [email protected].

Weekend reads: ‘Honest overachievers;’ the unpublished Lucy Letby paper; ‘atom-thin salami slicing’

Dear RW readers, can you spare $25?

The week at Retraction Watch featured:

Introducing the Retraction Watch Sleuth in Residence Program

Introducing the Retraction Watch Sleuth in Residence Program

We’re thrilled to announce the creation of the Retraction Watch Sleuth in Residence Program, an opportunity for a sleuth to spend a year working with us.

Too often, sleuths work for free, often at great legal and personal risk. We want to build capacity in this space so others see the value of compensating and protecting the critical work of sleuths.

The goal of this program – funded by a generous donation from George Tidmarsh – is to offer a secure and paid position for an active sleuth with a proven track record. The Sleuth in Residence would work closely with our research team on specific projects, and with our journalism team to publish their findings. All of that work would go through rigorous review and be covered by our defamation insurance policy.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: